New Treatment for Infection of the NIPRO LVAD Cannula Site: Nihon University Crystal Violet Method

Driveline and cannula site infections are still a frequent adverse event in patients with a ventricular assist device (VAD), and it is important to treat and prevent them because the spread of local infection may cause sepsis in some cases. We report our experience with a patient in whom infection o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of thoracic surgery 2016, Vol.101 (1), p.348-350
Hauptverfasser: Sezai, Akira, MD, PhD, Niino, Tetsuya, MD, PhD, Osaka, Shunji, MD, PhD, Yaoita, Hiroko, MD, Arimoto, Munehito, MD, Hata, Hiroaki, MD, PhD, Shiono, Motomi, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 350
container_issue 1
container_start_page 348
container_title The Annals of thoracic surgery
container_volume 101
creator Sezai, Akira, MD, PhD
Niino, Tetsuya, MD, PhD
Osaka, Shunji, MD, PhD
Yaoita, Hiroko, MD
Arimoto, Munehito, MD
Hata, Hiroaki, MD, PhD
Shiono, Motomi, MD, PhD
description Driveline and cannula site infections are still a frequent adverse event in patients with a ventricular assist device (VAD), and it is important to treat and prevent them because the spread of local infection may cause sepsis in some cases. We report our experience with a patient in whom infection of the NIPRO LVAD cannula site after implantation of an extracorporeal VAD was controlled by treatment with crystal violet Solbase (Nihon University crystal violet method).
doi_str_mv 10.1016/j.athoracsur.2015.04.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1751672102</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003497515006049</els_id><sourcerecordid>1751672102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-b874a1240fb8fc85bdbc01074d5b3fc6340faf60799da4ea429d07e22ee295c33</originalsourceid><addsrcrecordid>eNqNkc9u1DAQhy0EokvhFZCPXBLGjp1sOCCVpcBKS4von6vlOBOtl6xdbKfVvg3PwpPh1RYq9cTJsn7fzNjfEEIZlAxY_XZT6rT2QZs4hZIDkyWIEqB9QmZMSl7UXLZPyQwAqkK0jTwiL2Lc5CvP8XNyxOu6FbyRM9Kf4R29DKjTFl2igw906QY0yXpH_UDTGn__Olt--35OV9cnH-lCOzeNml7YhO9yYteZu3L2FkO0aUcXYReTHum19SMm-hXzO_uX5Nmgx4iv7s9jcvXp9HLxpVidf14uTlaFkUKmops3QjMuYOjmg5nLru8MMGhEL7tqMHWVEz3U0LRtrwVqwdseGuQckbfSVNUxeXPoexP8zwljUlsbDY6jduinqFgjWd1wBjyj8wNqgo8x4KBugt3qsFMM1N6x2qgHx2rvWIFQ2XEufX0_Zeq22P8r_Cs1Ax8OAOa_3loMKhqLzmBvQzarem__Z8r7R03MaJ01evyBO4wbPwWXXSqmIlegLva73q-aSYAaRFv9AaToqOY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1751672102</pqid></control><display><type>article</type><title>New Treatment for Infection of the NIPRO LVAD Cannula Site: Nihon University Crystal Violet Method</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Sezai, Akira, MD, PhD ; Niino, Tetsuya, MD, PhD ; Osaka, Shunji, MD, PhD ; Yaoita, Hiroko, MD ; Arimoto, Munehito, MD ; Hata, Hiroaki, MD, PhD ; Shiono, Motomi, MD, PhD</creator><creatorcontrib>Sezai, Akira, MD, PhD ; Niino, Tetsuya, MD, PhD ; Osaka, Shunji, MD, PhD ; Yaoita, Hiroko, MD ; Arimoto, Munehito, MD ; Hata, Hiroaki, MD, PhD ; Shiono, Motomi, MD, PhD</creatorcontrib><description>Driveline and cannula site infections are still a frequent adverse event in patients with a ventricular assist device (VAD), and it is important to treat and prevent them because the spread of local infection may cause sepsis in some cases. We report our experience with a patient in whom infection of the NIPRO LVAD cannula site after implantation of an extracorporeal VAD was controlled by treatment with crystal violet Solbase (Nihon University crystal violet method).</description><identifier>ISSN: 0003-4975</identifier><identifier>EISSN: 1552-6259</identifier><identifier>DOI: 10.1016/j.athoracsur.2015.04.009</identifier><identifier>PMID: 26694275</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Administration, Topical ; Adult ; Anti-Infective Agents, Local - administration &amp; dosage ; Cardiothoracic Surgery ; Catheters - adverse effects ; Catheters - microbiology ; Gentian Violet - administration &amp; dosage ; Heart Failure - therapy ; Heart-Assist Devices - adverse effects ; Humans ; Male ; Ointments ; Prosthesis-Related Infections - drug therapy ; Prosthesis-Related Infections - etiology ; Prosthesis-Related Infections - microbiology ; Surgery</subject><ispartof>The Annals of thoracic surgery, 2016, Vol.101 (1), p.348-350</ispartof><rights>The Society of Thoracic Surgeons</rights><rights>2016 The Society of Thoracic Surgeons</rights><rights>Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-b874a1240fb8fc85bdbc01074d5b3fc6340faf60799da4ea429d07e22ee295c33</citedby><cites>FETCH-LOGICAL-c545t-b874a1240fb8fc85bdbc01074d5b3fc6340faf60799da4ea429d07e22ee295c33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.athoracsur.2015.04.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3554,4028,27932,27933,27934,46004</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26694275$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sezai, Akira, MD, PhD</creatorcontrib><creatorcontrib>Niino, Tetsuya, MD, PhD</creatorcontrib><creatorcontrib>Osaka, Shunji, MD, PhD</creatorcontrib><creatorcontrib>Yaoita, Hiroko, MD</creatorcontrib><creatorcontrib>Arimoto, Munehito, MD</creatorcontrib><creatorcontrib>Hata, Hiroaki, MD, PhD</creatorcontrib><creatorcontrib>Shiono, Motomi, MD, PhD</creatorcontrib><title>New Treatment for Infection of the NIPRO LVAD Cannula Site: Nihon University Crystal Violet Method</title><title>The Annals of thoracic surgery</title><addtitle>Ann Thorac Surg</addtitle><description>Driveline and cannula site infections are still a frequent adverse event in patients with a ventricular assist device (VAD), and it is important to treat and prevent them because the spread of local infection may cause sepsis in some cases. We report our experience with a patient in whom infection of the NIPRO LVAD cannula site after implantation of an extracorporeal VAD was controlled by treatment with crystal violet Solbase (Nihon University crystal violet method).</description><subject>Administration, Topical</subject><subject>Adult</subject><subject>Anti-Infective Agents, Local - administration &amp; dosage</subject><subject>Cardiothoracic Surgery</subject><subject>Catheters - adverse effects</subject><subject>Catheters - microbiology</subject><subject>Gentian Violet - administration &amp; dosage</subject><subject>Heart Failure - therapy</subject><subject>Heart-Assist Devices - adverse effects</subject><subject>Humans</subject><subject>Male</subject><subject>Ointments</subject><subject>Prosthesis-Related Infections - drug therapy</subject><subject>Prosthesis-Related Infections - etiology</subject><subject>Prosthesis-Related Infections - microbiology</subject><subject>Surgery</subject><issn>0003-4975</issn><issn>1552-6259</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc9u1DAQhy0EokvhFZCPXBLGjp1sOCCVpcBKS4von6vlOBOtl6xdbKfVvg3PwpPh1RYq9cTJsn7fzNjfEEIZlAxY_XZT6rT2QZs4hZIDkyWIEqB9QmZMSl7UXLZPyQwAqkK0jTwiL2Lc5CvP8XNyxOu6FbyRM9Kf4R29DKjTFl2igw906QY0yXpH_UDTGn__Olt--35OV9cnH-lCOzeNml7YhO9yYteZu3L2FkO0aUcXYReTHum19SMm-hXzO_uX5Nmgx4iv7s9jcvXp9HLxpVidf14uTlaFkUKmops3QjMuYOjmg5nLru8MMGhEL7tqMHWVEz3U0LRtrwVqwdseGuQckbfSVNUxeXPoexP8zwljUlsbDY6jduinqFgjWd1wBjyj8wNqgo8x4KBugt3qsFMM1N6x2qgHx2rvWIFQ2XEufX0_Zeq22P8r_Cs1Ax8OAOa_3loMKhqLzmBvQzarem__Z8r7R03MaJ01evyBO4wbPwWXXSqmIlegLva73q-aSYAaRFv9AaToqOY</recordid><startdate>2016</startdate><enddate>2016</enddate><creator>Sezai, Akira, MD, PhD</creator><creator>Niino, Tetsuya, MD, PhD</creator><creator>Osaka, Shunji, MD, PhD</creator><creator>Yaoita, Hiroko, MD</creator><creator>Arimoto, Munehito, MD</creator><creator>Hata, Hiroaki, MD, PhD</creator><creator>Shiono, Motomi, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2016</creationdate><title>New Treatment for Infection of the NIPRO LVAD Cannula Site: Nihon University Crystal Violet Method</title><author>Sezai, Akira, MD, PhD ; Niino, Tetsuya, MD, PhD ; Osaka, Shunji, MD, PhD ; Yaoita, Hiroko, MD ; Arimoto, Munehito, MD ; Hata, Hiroaki, MD, PhD ; Shiono, Motomi, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-b874a1240fb8fc85bdbc01074d5b3fc6340faf60799da4ea429d07e22ee295c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Administration, Topical</topic><topic>Adult</topic><topic>Anti-Infective Agents, Local - administration &amp; dosage</topic><topic>Cardiothoracic Surgery</topic><topic>Catheters - adverse effects</topic><topic>Catheters - microbiology</topic><topic>Gentian Violet - administration &amp; dosage</topic><topic>Heart Failure - therapy</topic><topic>Heart-Assist Devices - adverse effects</topic><topic>Humans</topic><topic>Male</topic><topic>Ointments</topic><topic>Prosthesis-Related Infections - drug therapy</topic><topic>Prosthesis-Related Infections - etiology</topic><topic>Prosthesis-Related Infections - microbiology</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sezai, Akira, MD, PhD</creatorcontrib><creatorcontrib>Niino, Tetsuya, MD, PhD</creatorcontrib><creatorcontrib>Osaka, Shunji, MD, PhD</creatorcontrib><creatorcontrib>Yaoita, Hiroko, MD</creatorcontrib><creatorcontrib>Arimoto, Munehito, MD</creatorcontrib><creatorcontrib>Hata, Hiroaki, MD, PhD</creatorcontrib><creatorcontrib>Shiono, Motomi, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sezai, Akira, MD, PhD</au><au>Niino, Tetsuya, MD, PhD</au><au>Osaka, Shunji, MD, PhD</au><au>Yaoita, Hiroko, MD</au><au>Arimoto, Munehito, MD</au><au>Hata, Hiroaki, MD, PhD</au><au>Shiono, Motomi, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New Treatment for Infection of the NIPRO LVAD Cannula Site: Nihon University Crystal Violet Method</atitle><jtitle>The Annals of thoracic surgery</jtitle><addtitle>Ann Thorac Surg</addtitle><date>2016</date><risdate>2016</risdate><volume>101</volume><issue>1</issue><spage>348</spage><epage>350</epage><pages>348-350</pages><issn>0003-4975</issn><eissn>1552-6259</eissn><abstract>Driveline and cannula site infections are still a frequent adverse event in patients with a ventricular assist device (VAD), and it is important to treat and prevent them because the spread of local infection may cause sepsis in some cases. We report our experience with a patient in whom infection of the NIPRO LVAD cannula site after implantation of an extracorporeal VAD was controlled by treatment with crystal violet Solbase (Nihon University crystal violet method).</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>26694275</pmid><doi>10.1016/j.athoracsur.2015.04.009</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-4975
ispartof The Annals of thoracic surgery, 2016, Vol.101 (1), p.348-350
issn 0003-4975
1552-6259
language eng
recordid cdi_proquest_miscellaneous_1751672102
source MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Administration, Topical
Adult
Anti-Infective Agents, Local - administration & dosage
Cardiothoracic Surgery
Catheters - adverse effects
Catheters - microbiology
Gentian Violet - administration & dosage
Heart Failure - therapy
Heart-Assist Devices - adverse effects
Humans
Male
Ointments
Prosthesis-Related Infections - drug therapy
Prosthesis-Related Infections - etiology
Prosthesis-Related Infections - microbiology
Surgery
title New Treatment for Infection of the NIPRO LVAD Cannula Site: Nihon University Crystal Violet Method
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T09%3A29%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20Treatment%20for%20Infection%20of%20the%C2%A0NIPRO%20LVAD%20Cannula%20Site:%C2%A0Nihon%20University%20Crystal%20Violet%20Method&rft.jtitle=The%20Annals%20of%20thoracic%20surgery&rft.au=Sezai,%20Akira,%20MD,%20PhD&rft.date=2016&rft.volume=101&rft.issue=1&rft.spage=348&rft.epage=350&rft.pages=348-350&rft.issn=0003-4975&rft.eissn=1552-6259&rft_id=info:doi/10.1016/j.athoracsur.2015.04.009&rft_dat=%3Cproquest_cross%3E1751672102%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1751672102&rft_id=info:pmid/26694275&rft_els_id=S0003497515006049&rfr_iscdi=true